Tempus AI, Inc. (NASDAQ:TEM) Receives $71.83 Consensus PT from Brokerages

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been given a consensus rating of “Hold” by the fourteen research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $71.8333.

TEM has been the topic of a number of research analyst reports. Guggenheim increased their target price on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 26th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday. BTIG Research increased their target price on Tempus AI from $75.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday, August 20th. Bank of America increased their target price on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Finally, Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a report on Friday, August 8th.

Tempus AI Stock Up 11.0%

TEM stock opened at $103.25 on Thursday. Tempus AI has a twelve month low of $31.36 and a twelve month high of $103.42. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The company has a market capitalization of $17.94 billion, a P/E ratio of -86.76 and a beta of 4.87. The firm has a 50 day simple moving average of $77.21 and a 200-day simple moving average of $64.16.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. During the same quarter last year, the company earned ($6.86) earnings per share. The business’s quarterly revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Tempus AI will post -6.15 earnings per share for the current fiscal year.

Insider Activity at Tempus AI

In other news, COO Ryan Fukushima sold 17,460 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the completion of the transaction, the chief operating officer directly owned 839,180 shares of the company’s stock, valued at approximately $62,644,787. This represents a 2.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Theodore Leonsis sold 44,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $69.90, for a total value of $3,075,600.00. Following the transaction, the director directly owned 86,756 shares of the company’s stock, valued at $6,064,244.40. This trade represents a 33.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 933,662 shares of company stock worth $68,070,993 over the last quarter. 26.27% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Tempus AI

Several institutional investors have recently made changes to their positions in the stock. Balefire LLC grew its holdings in shares of Tempus AI by 2.5% during the third quarter. Balefire LLC now owns 14,026 shares of the company’s stock valued at $1,132,000 after purchasing an additional 336 shares during the last quarter. Venture Visionary Partners LLC grew its holdings in shares of Tempus AI by 305.2% during the third quarter. Venture Visionary Partners LLC now owns 57,368 shares of the company’s stock valued at $4,630,000 after purchasing an additional 43,211 shares during the last quarter. GAMMA Investing LLC bought a new position in shares of Tempus AI during the third quarter valued at approximately $28,000. China Universal Asset Management Co. Ltd. grew its holdings in shares of Tempus AI by 0.7% during the second quarter. China Universal Asset Management Co. Ltd. now owns 33,757 shares of the company’s stock valued at $2,145,000 after purchasing an additional 226 shares during the last quarter. Finally, Marex Group plc bought a new position in shares of Tempus AI during the second quarter valued at approximately $26,620,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.